A charity investing in ME research
ME Research UK is a charity with the primary aim of funding high-quality biomedical research into the causes, consequences and…
Orexins and GLP-1s as they relate to long COVID and ME/CFS
A recent review highlighted the devastating multi-system effects of COVID on the body, particularly emphasising the endocrinological (hormonal) consequences manifesting…
Molecular understanding of ME/CFS: Genetics
Genetics (the study of segments of DNA called genes) and epigenetics (how environmental and other factors impact gene activity) are becoming…
No plans to develop a separate specification for severe and very severe ME/CFS
When the ME/CFS Delivery Plan was published in July 2025 the Provision of Health Services section stated that the “DHSC,…
Markers in cerebrospinal fluid linked with ME/CFS disease heterogeneity
In 2023, Dr Bo Bertilson, a researcher and clinician at the Department of Neurobiology, Care Sciences and Society, Karolinska Institutet,…
Fundraising Focus – June 2026
Each month, Fundraising Focus is our way of saying thank you and celebrate the people behind the fundraising.
Movement for Good 2026 Winner – ME Research UK
ME Research UK is one of 10 winners in Benefact Group’s May 2026 Health and Wellbeing prize draw. The prize…
ME Research UK – e-newsletter May 2026
ME Awareness Week – A Recap Living with ME/CFS can be incredibly isolating, often due to major shifts in life…
Predatory journals – what are they, and what could they mean for ME/CFS research?
Predatory publishing, also known as deceptive or write-only publishing, occurs where journals charge authors publication fees without providing the legitimate…
Researcher Circle
On the 23rd of April 2026, the fourth meeting of ME Research UK’s ‘Researcher Circle’ took place online. The Circle meets…
Pre-print – The case against deconditioning as the cause of ME/CFS
Last May, a team of researchers led by Braeden Charlton and including ME Research UK-funded researcher Associate Professor Rob Wüst…
